-
Stokes set for England return in New Zealand finale - reports
-
McIlroy pleased with reduced green speeds in US Open winds
-
Quarantine over for almost all hantavirus ship passengers, crew
-
US stocks resume upward climb as dollar advances again after Fed outlook
-
Ex-presidents and stars, but no Trump, turn out for Obama Library
-
Stevens seizes US Open lead with McIlroy, Aberg one back
-
Al-Qaeda-linked jihadists attack Niger airport, 11 soldiers killed
-
'Big-game' Bellingham shows his worth for England at World Cup
-
New Zealand's Henry rocks England in 2nd Test after Phillips century
-
Vance warns Israel against criticizing US-Iran deal
-
Iran's supreme leader says approved deal as US lifts ports blockade
-
Australian qualifier Hijikata shocks Lehecka at Queen's Club
-
AI-generated videos use Down syndrome to make sales
-
O'Brien's royal century reward for sacrificing all for racing
-
Spurs sign Dutch defender Van Hecke from Brighton
-
England great Botham slams Stokes for breaking curfew
-
Liverpool agree deal to sign Spain forward Munoz from Osasuna
-
Chivu extends Inter deal until 2028 after debut season double triumph
-
New Zealand's Henry rocks England after Phillips century
-
Ghana pushes for concrete slavery reparations
-
Wildcard Eala shocks Rybakina in Berlin
-
Robertson and Scotland eye World Cup history against Morocco
-
South Africa hold Czechs, keep World Cup knockout dream alive
-
Joyful New York celebrates Knicks with ticker-tape parade
-
Important or selfish? World Cup evidence mounts against Ronaldo
-
Europe risks 'total irrelevance' without sovereign tech: Cohere chief
-
EU wrestles over tackling China export flood
-
Ex-presidents, stars, but no Trump, turn out for Obama Center
-
Vance defends Iran deal, eyes Swiss talks
-
US Olympic athlete Simpson shows 'improvement' after collasing on track
-
Wahi granted Canadian visa for Ivory Coast World Cup match after delay
-
Israel FM cuts contact with EU top diplomat over 'apartheid' remarks
-
US lifts Iran ports blockade as uncertainty clouds Swiss Iran talks
-
Brazilian police probe senator close to Lula
-
Brutal Shinnecock winds blow away US Open contenders
-
Leverkusen sign Portuguese talent Moreira from Lyon
-
AI-generated videos wield Down syndrome to make sales
-
Suspected jihadists stage deadly new attack on Niger airport
-
Man dies, trains and classes disrupted as heatwave hits France
-
Oil sinks on Mideast deal, but Fed outlook knocks equities
-
Neymar to miss Brazil's second World Cup game against Haiti
-
Dupont to start for Toulouse in Top 14 semi, Ramos out
-
O'Brien's historic 100th Royal Ascot winner has golden glow
-
Zverev wins all-German duel with Hanfmann to reach Halle quarters
-
Graft probe into Spanish ex-PM expanded to daughters
-
Iran war leaves Islamic republic intact and opponents divided
-
Gregoire wins Swiss tour 2nd stage as Pogacar extends lead
-
Galthie confirms Edwards to exit in France rugby coaching shake-up
-
What Real Madrid's new signings add to Mourinho's project
-
Knicks celebrate NBA win with huge New York parade
Applications are Open for the 2026 Semmelweis-Richter Journalism Award Until June 9th
BUDAPEST, HUNGARY / ACCESS Newswire / May 28, 2026 / After the strong success of its first edition, the Semmelweis-Richter Journalism Award returns in 2026. Journalists from eligible European countries are invited to submit entries in two categories: Women's Health and Pharmaceutical Strategies and Innovation, with a special focus on cardiovascular therapies. The application deadline is June 9, 2026, 23:59 CET.
The international award was first launched in 2025 by Semmelweis University, Hungary's leading medical and health sciences university, with the support of Gedeon Richter, a Hungary-based, innovation-focused multinational pharmaceutical company. The award aims to recognise high-quality health journalism and its role in informing the public and shaping health-related debate across Europe.
The first edition attracted wide international interest, with nearly 70 submissions from more than 20 European countries, including the United Kingdom, Germany, and Russia. Entries were published in leading international outlets such as The Times, The Guardian, La República, and Süddeutsche Zeitung.
Building on this strong debut, the award is again open in 2026 in the same two categories: Women's Health and Pharmaceutical Strategies and Innovation, with a special focus on cardiovascular therapies.
The organisers are looking for articles that highlight important health issues, address underreported or stigmatized conditions, encourage open public discussion, and help improve understanding and treatment.
An international jury will evaluate submissions based on journalistic quality, depth of reporting, impact and relevance, originality, and clear communication.
Submission guidelines
Each applicant may submit up to two articles, one per category.
Eligible articles must have been published between March 1, 2025 and March 31, 2026.
Print articles must be submitted as a scanned copy; online articles as a public link; paywalled content as a screenshot.
Submissions must be in English or include an English translation (the original version must also be provided).
Applications must be submitted online at: https://semmelweisrichteraward.com/
Awards
The winners will be announced in the last week of July 2026.
The total prize fund is €45,000. In each category, first prize is €10,000, second prize €7,500, and third prize €5,000.
All six winners will be invited to the award ceremony in October 2026 at Semmelweis University in Budapest, Hungary, with travel and accommodation fully covered.
Contact Information
SOURCE: Gedeon Richter Plc.
View the original press release on ACCESS Newswire
L.Dubois--BTB